SynthesisJournal of neurology2026
Ultrasonography demonstrates vagus nerve atrophy in Parkinson's disease: a meta-analysis.
Synthesis in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundParkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms, including autonomic dysfunction. Increasing evidence suggests that PD pathology may originate in the enteric nervous system and propagate to the brain via the vagus nerve. Accordingly, structural alterations of the vagus nerve could reflect disease-related neurodegeneration and may serve as a biomarker for PD. Vagus nerve ultrasound enables non-invasive measurement of the vagus nerve by measuring the cross-sectional area (CSA). However, existing studies report conflicting findings regarding vagus nerve CSA in PD. This meta-analysis evaluates whether vagus nerve CSA is decreased in persons with PD compared to controls.
methodsOnline databases were searched up to January, 2026, for studies measuring the CSA of the vagus nerve in PD patients using ultrasound. Twelve studies with a total of 1091 participants (541 PD and 550 controls) were included. Inclusion criteria encompassed peer-reviewed studies with PD patients and controls. Quality assessment was conducted using the Newcastle-Ottawa Scale. Meta-analysis was performed using a random effects model accounting for between-study heterogeneity.
resultsThis meta-analysis showed a statistically significant reduction in CSA of PD patients compared to the controls. The mean CSA of the right and left vagus nerve was 1.97 mm
conclusionsOn a group level, there is a reduction of CSA of the vagus nerve in PD patients measured by ultrasound.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.